Navigation Links
Bioniche Reports Fiscal 2008 First Quarter
Date:11/9/2007

revenues down due to non-recurring event in 2007, net loss stable

(all figures are in Canadian dollars unless otherwise noted)

BELLEVILLE, ON, Nov. 9 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the first quarter of its 2008 fiscal year, ending September 30, 2007.

"We are also focused on the successful completion of a marketing partnership deal for Urocidin - our bladder cancer therapy, while executing our Phase III clinical program, the first trial of which continues to recruit patients at 25 centres in the U.S. and Canada," said Graeme McRae, President & CEO of Bioniche Life Sciences Inc. "We also continue to be focused on obtaining a full Canadian license for our E. coli O157:H7 cattle vaccine, while seeking an opportunity to clarify statistical analysis methodology with our U.S. regulator."

Fiscal 2008 First Quarter Financial Results Highlights

Consolidated revenues for the first quarter totaled $5.9 million, a decrease of 23% from the $7.7 million recorded in the same period in Fiscal 2007. A one-time promotion of a leading animal health product contributed to higher revenues for the first quarter last year, an event that was not repeated this year.

The overall gross profit margin was 58% for the first quarter of Fiscal 2008, as compared to 59% for the same period in Fiscal 2007.

Expenses totaled $4.1 million for the three months ending September 30, 2007, which compares to $3.8 million recorded in the same period last year. This increase of $0.3 million, or 8%, primarily reflects additional staff, increased expenditures on E. coli O157:H7 development and awareness program and some necessary salary increases.

Gross research and development expenses remained stable at $3.6 million for the 3-month periods ending September 30, 2007 and September 30, 2006 respectively. The majo
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Bioniche Responds to Australian Equine Influenza Outbreak
2. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
3. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
4. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
5. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
6. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
8. Haemacure Reports Third Quarter 2007 Results
9. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
10. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
11. MDS Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... Medical Solutions, one of the nation’s largest travel ... in Healthcare by Modern Healthcare and will be honored at an awards dinner ... year, the Best Places to Work in Healthcare program recognizes outstanding employers in the ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... for its adolescent residential, counseling, day treatment and intensive family based services. , ... standards for quality and its pursuit of excellence. As a nonprofit charity for ...
(Date:8/28/2015)... ... August 28, 2015 , ... SmartPractice ... low cost. Personalized with practice contact information and logos, Calendars stand alone as ... also incorporate Calendars into seasonal mailings, thank you and welcome communications, and to ...
(Date:8/28/2015)... ... 28, 2015 , ... Northridge dentists Dr. Elyson and Dr. Assili ... patients can currently receive a one hour treatment of this teeth whitening option. ... a number of unique features that can turn teeth up to nine shades whiter. ...
(Date:8/28/2015)... ... August 28, 2015 , ... SharkNinja, an ... coffee connoisseur and Emmy-nominated actress, Sofia Vergara, and unveil the Ninja® brand’s ... Extraction™ technology, which delivers a variety of sizes and styles while achieving the ...
Breaking Medicine News(10 mins):Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3
... of California, chemists have taken snapshots of the ... professor of chemistry at the UC Berkeley, reported ... than the width of a human hair an ... generated great excitement in the opto-electronics community because ...
... strategy was developed - using a natural compound to ... in the cellular reservoirs of the body. Prostratin, an ... stimulate the virus, which causes AIDS, in a way ... attack it.// , Dr. Roger Pomerantz, chief of ...
... to a study, exercise can help older people avert ... such as standing up and walking an impossible one.Those ... likely to lose abilities to perform activities of daily ... of Medicine, Texas, this report is the first to ...
... identified a gene that causes benign moles on the skin ... effectively patients with early stages of melanoma. ,A ... Hopkins University, found a gene known as Id1 that causes ... suppressor gene that ordinarily keeps precancerous moles from progressing to ...
... developed by Australians which may replace the PAP smear, it ... well as Australia. ,Sydney-based Polartechnics Ltd has developed the ... it offers instant results and greater ccuracy than PAP smears. ... directly from the cervix about the colour// and electrical properties ...
... the development of an artificial vision system for a ... acuity of about 20/400. ,The system uses ... both of which are mounted on a pair of ... miniature computer which is worn on a belt. After ...
Cached Medicine News:Health News:Discovery of World’s smallest laser 2Health News:Prostratin- Drug to eradicate HIV 2Health News:Arthritis risk reduced by exercise 2Health News:Gene causes moles to become cancerous 2
(Date:8/28/2015)... , Aug. 28, 2015 ... has announced the addition of the "Investigation ... to their offering. Developed by AstraZeneca ... is an important drug for the treatment of ... 2000, quetiapine was listed in the Catalogue of ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... report to their offering. Developed by ... selective prostaglandin receptor agonist which effectively reduces intraocular ... by FDA, latanoprost (under the trade name of ...
(Date:8/28/2015)... KONG , August 28, 2015 ... in collaboration with one of the leading academics in ... (current world record holder in life extension for model ... insights into biology of aging and age-related diseases, primarily, around ... The work has just been published as "Stability analysis of ...
Breaking Medicine Technology:China Quetiapine Market Investigation Report 2010-2019 2China Latanoprost Market Investigation Report 2015-2019 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3
... At the end of 2009, the vaccine industry raised ... business media were occupied by various kinds of news ... successfully landed on the Nasdaq, then Simcere, a pharmaceutical ... announced a 50.8% stake in Ealong Biotech and took ...
... EAST HANOVER, N.J., Oct. 16 Novartis announced today ... safety profile of once-yearly Reclast® (zoledronic acid) injection in ... 1,200 women was presented this weekend at the annual ... Research (ASBMR) in Toronto, ON, Canada. The ...
Cached Medicine Technology:Vaccine Leaders All Over the World Talking About China Vaccine Opportunities at VacChina 2010 -- the No.1 China Focused Vaccine Partnering Forum 2Long-Term Data Show Novartis Once-Yearly Reclast Preserves Bone Mass and Provides Fracture Protection in Postmenopausal Osteoporosis 2Long-Term Data Show Novartis Once-Yearly Reclast Preserves Bone Mass and Provides Fracture Protection in Postmenopausal Osteoporosis 3Long-Term Data Show Novartis Once-Yearly Reclast Preserves Bone Mass and Provides Fracture Protection in Postmenopausal Osteoporosis 4Long-Term Data Show Novartis Once-Yearly Reclast Preserves Bone Mass and Provides Fracture Protection in Postmenopausal Osteoporosis 5Long-Term Data Show Novartis Once-Yearly Reclast Preserves Bone Mass and Provides Fracture Protection in Postmenopausal Osteoporosis 6
Hydrodissection / Aspiration Cannula, 25 g. Straight with U-tip. U-shaped tip allows aspiration and irrigation at the 12 o'clock position. Overall length 18 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Angled with left hook. 10 mm angled shaft with 2.5 mm left hook tip. Overall length 20 mm. 5/box....
Retinal Hydrodissection Cannula. 20 gauge shaft tapers to 41 gauge I.D. flexible tip. Packaged sterile. 5/Box....
Posterior Capsule Polisher, 23 g., 30 angle small gauge with roughened tip, open end port. Overall length 16 mm. 5/box....
Medicine Products: